Geneva:
The Swiss medicines company Swissmedic on Friday authorised the vaccination of kids aged between 5 and 11 with Pfizer-Biontech’s Comirnaty vaccine.
“Scientific trial outcomes present that the vaccine is protected and efficient on this age group,” it stated in a press release.
The Comirnaty vaccine is run in two doses of ten microgrammes three weeks aside.
An ongoing scientific trial of greater than 1,500 folks “exhibits that the Covid-19 vaccine provides nearly full safety towards critical sickness brought on by the SARS-CoV-2 virus in 5 to 11-year-olds”, it stated.
“Uncomfortable side effects tended to happen much less incessantly than in adolescents or adults. They included ache on the injection web site and tiredness, or much less incessantly headache, aching limbs or fever,” the company added.
The vaccinations had been till now restricted to kids aged 12 or older.
Switzerland is at the moment experiencing a robust fifth wave of the virus.
Solely the Comirnaty and Moderna vaccine are authorised in Switzerland.
The nation joins Portugal, Italy, Greece and Spain in Europe in giving the inexperienced mild to the vaccination of kids on this age group.
Canada and america in addition to Israel and Chile have additionally authorised the vaccination of kids of an identical age.
In France, vaccination has solely been authorised for younger kids prone to growing critical sickness however the authorities has stated it’s contemplating extending it to all kids on a voluntary foundation.
(Apart from the headline, this story has not been edited by NDTV workers and is revealed from a syndicated feed.)